These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36440903)

  • 1. Impact of oral naloxegol vs subcutaneous methylnaltrexone in treatment of opioid-induced constipation in the hospital setting.
    Nero R; Allen B; Hailu K; Noor R; Theiss K
    Am J Health Syst Pharm; 2023 May; 80(Suppl 2):S70-S76. PubMed ID: 36440903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
    Tobben D; Carpenter S; Kolar R; Merritt T; Young T; Hauser P; Collier T
    Ann Pharmacother; 2024 Jul; 58(7):678-684. PubMed ID: 37881915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Pharmacist-Driven Protocol for the Treatment of Opioid-Induced Constipation.
    Tryson AR; Hennessey EK; Crannage AJ
    J Pharm Pract; 2022 Apr; 35(2):218-222. PubMed ID: 35484871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Peripheral μ-Opioid Receptor Antagonists for Treating Opioid-Induced Constipation among US Medicare Beneficiaries from 2014 to 2018.
    Premnath N; Sumarsono A; Sedhom R; Johnson DH; Subbiah IM; Dy SM; Gupta A
    J Palliat Med; 2021 Aug; 24(8):1236-1239. PubMed ID: 33872062
    [No Abstract]   [Full Text] [Related]  

  • 7. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety.
    Pergolizzi JV; Christo PJ; LeQuang JA; Magnusson P
    Drug Des Devel Ther; 2020; 14():1009-1025. PubMed ID: 32210534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
    Habeeb EA; Tran LK; Goodberlet MZ; Lupi KE; DeGrado JR; Dube KM
    Ann Pharmacother; 2023 Jul; 57(7):762-768. PubMed ID: 36314271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripherally acting μ-opioid receptor antagonists for treatment of opioid-induced constipation in children.
    Novak C; Hogg A; Sue K; Davies D
    Paediatr Child Health; 2021; 26(2):e105-e109. PubMed ID: 33747318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
    Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM; Bilsky EJ
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of methylnaltrexone in pediatric oncology patients: A single center experience.
    Koranteng L; Mauguen A; Butler M; Yan SQ; Taylor D
    J Oncol Pharm Pract; 2024 Jan; 30(1):4-8. PubMed ID: 36946143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB; Kowey P; Diva U; Sostek M; Tummala R
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxegol rescue with methylnaltrexone highly effective.
    Brocklebank J; Miller EJ; Fingas S
    BMJ Support Palliat Care; 2020 Sep; 10(3):316-317. PubMed ID: 32709705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study.
    Cobo Dols M; Beato Zambrano C; Cabezón-Gutiérrez L; Chicas-Sett R; Blancas López-Barajas MI; García Navalón FJ; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Huerta González I; Sanz-Yagüe A; Soler López B
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e318-e326. PubMed ID: 33707299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response Rates to Methylnaltrexone in Hospitalized Cancer Patients.
    Harris D; Kalir D; Chevalier C; Dobbie K; Fielding F; Lagman R; Makhoul A; McInnes S; Najafi S; Neale K; Rybicki L; Robbins-Ong M; Neuendorf K
    Am J Hosp Palliat Care; 2023 Oct; 40(10):1093-1097. PubMed ID: 36565253
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ
    Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
    De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
    Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxegol for opioid-induced constipation in patients with noncancer pain.
    Chey WD; Webster L; Sostek M; Lappalainen J; Barker PN; Tack J
    N Engl J Med; 2014 Jun; 370(25):2387-96. PubMed ID: 24896818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
    Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.